Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.
Learn from industry leaders how the Shared Investigator Platform standardizes documents, eliminates inconsistencies and speeds clinical trials.WATCH VIDEO
Cognizant SIP solutions for virtual monitoring, study oversight, document exchange and collaboration, and Oracle’s study startup workflows and predictive analytics, improve clinical trial efficiencies and enable stakeholders to conduct studies virtually.VIEW WEBINAR
Shared Investigator Platform (SIP) is a multi-sponsor collaborative solution for clinical trial site selection, start-up communications and management. The open design of Cognizant’s Shared Investigator Platform simplifies and accelerates clinical trials by eliminating redundant work for sponsors and clinical sites.WATCH VIDEO
Learn how the Cognizant® Shared Investigator Platform helps sponsors meet today’s challenges while providing a better trial experience for clinical researchers.READ BROCHURE
Learn how Cognizant® Shared Investigator Platform makes it easy for sites to collaborate with sponsors.READ BROCHURE
Cognizant SIP is a robust platform that transforms how sponsors and sites collaborate throughout key components of the clinical trial lifecycle.READ DATASHEET
The COVID-19 pandemic has forced sponsors to find new ways to virtually visit investigators. The video meeting capability in Cognizant SIP streamlines and optimizes collaboration throughout the clinical trial life cycle.READ DATASHEET
As current social distancing guidelines prevent most face-to-face clinical trials, now’s the time to move to decentralized clinical trials.
Keeping clinical trials operating efficiently during the COVID-19 pandemic is forcing the life sciences industry to adopt new working practices.